EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma

Lei He iD, Zhaozhao Li, Danjie Su, Haichen Du, Kuo Zhang, Wangqian Zhang, Shuning Wang, Fei Xie, Yueyuan Qiu, Shuangxin Ma, Gege Shi, Duo Yu und 6 weitere

Advanced Science · 2024-07 · 11 (26)

DOI: 10.1002/advs.202403858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.05.2024. Verfasst von Lei He und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Biopharmaceutics, School of Pharmacy, The Fourth M…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Tumor Microenvironment, Liver Neoplasms, CRISPR-Cas Systems. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has demonstrated significant efficacy in various tumors, but its effectiveness in treating Hepatocellular Carcinoma (HCC) remains limited. Therefore, there is an urgent need to identify a new immunotherapy target and develop corresponding intervention strategies. Bioinformatics analysis has revealed that growth differentiation factor 15 (GDF15) is highly expressed in HCC and is closely related to poor prognosis of HCC patients. The previous study revealed that GDF15 can promote immunosuppression in the tumor microenvironment. Therefore, knocking out GDF15 through gene editing could potentially reverse the suppressive tumor immune microenvironment permanently. To deliver the CRISPR/Cas9 system specifically to HCC, nanocapsules (SNC) coated with HCC targeting peptides (SP94) on their surface is utilized. These nanocapsules incorporate disulfide bonds (SNC SS ) that release their contents in the tumor microenvironment characterized by high levels of glutathione (GSH). In vivo, the SNC SS target HCC cells, exert a marked inhibitory effect on HCC progression, and promote HCC immunotherapy. Mechanistically, CyTOF analysis showed favorable changes in the immune microenvironment of HCC, immunocytes with killer function increased and immunocytes with inhibitive function decreased. These findings highlight the potential of the CRISPR‐Cas9 gene editing system in modulating the immune microenvironment and improving the effectiveness of existing immunotherapy approaches for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularTumor MicroenvironmentLiver NeoplasmsCRISPR-Cas SystemsNanocapsulesMiceHumansAnimalsImmunotherapyDisease Models, AnimalGene EditingCell Line, Tumor

Stichwörter der Autor:innen

CRISPR/Cas9GDF15hepatocellular carcinomaimmune microenvironmentnanocapsule

Substanzen

Nanocapsules

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Biopharmaceutics, School of Pharmacy, The Fourth Military Medical University, Xi'an, 710032, China.
  • Department of Obstetrics and Gynecology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China.
  • Department of Oncology, 940th Hospital, Joint Logistic Support Force, Lanzhou, 730050, China.
  • College of Life Sciences, Northwest University, Xi'an, 710069, China.
  • Department of Neurosurgery, General Hospital of Central Theater Command, Wuhan, 430012, China.

ORCID-Profile: Lei He

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi

Zitieren

APA

He, L., Li, Z., Su, D., Du, H., Zhang, K., Zhang, W., Wang, S., Xie, F., Qiu, Y., Ma, S., Shi, G., Yu, D., Lei, X., Li, W., Li, M., Wang, Z., Gu, J., & Zhang, Y. (2024). Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma. Advanced Science, 11(26). https://doi.org/10.1002/advs.202403858

Vancouver

He L, Li Z, Su D, Du H, Zhang K, Zhang W, et al. Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma. Advanced Science. 2024;11(26). doi:10.1002/advs.202403858

BibTeX
@article{He2024,
  author = {He, Lei and Li, Zhaozhao and Su, Danjie and Du, Haichen and Zhang, Kuo and Zhang, Wangqian and Wang, Shuning and Xie, Fei and Qiu, Yueyuan and Ma, Shuangxin and Shi, Gege and Yu, Duo and Lei, Xiaoying and Li, Weina and Li, Meng and Wang, Zhaowei and Gu, Jintao and Zhang, Yingqi},
  title = {Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {26},
  doi = {10.1002/advs.202403858}
}
Kostenlos starten →